The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The effects of targeting stromal and tumor cell platelet-derived growth factor receptor (PDGFR) in non-small cell lung cancer (NSCLC).
D. E. Gerber
Research Funding - ImClone Systems
P. Gupta
No relevant relationships to disclose
M. T. Dellinger
No relevant relationships to disclose
J. Toombs
No relevant relationships to disclose
I. Valencia
No relevant relationships to disclose
M. Peyton
No relevant relationships to disclose
N. Loizos
Employment or Leadership Position - ImClone Systems
Stock Ownership - ImClone Systems
R. A. Brekken
Research Funding - ImClone Systems